Effects of low dose endotoxemia on endothelial progenitor cells in humans

Atherosclerosis

Volumn 195, Issue 1, 2007, Pages

  Mayr, F B ^a   Spiel, A O ^a   Leitner, J M ^a   Firbas, C ^a   Sieghart, W ^a   Jilma, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Clinical trial; Endotoxin; EPC; Inflammation

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE;

ADULT; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; MALE; PRIORITY JOURNAL; STEM CELL;

ADULT; BODY MASS INDEX; BONE MARROW CELLS; COLONY-FORMING UNITS ASSAY; DOUBLE-BLIND METHOD; ENDOTHELIAL CELLS; ENDOTOXEMIA; ENDOTOXINS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; PLACEBOS; STEM CELLS; TREATMENT OUTCOME;

EID: 35248822179     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.04.003     Document Type: Article

References (29)

1. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9 (2003) 702-712
3. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
4. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
5. Chironi G., Walch L., Pernollet M.G., et al. Decreased number of circulating CD34(+)KDR(+) cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 191 (2007) 115-120
6. Wojakowski W., Tendera M., Michalowska A., et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110 (2004) 3213-3220
7. Grisar J., Aletaha D., Steiner C.W., et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111 (2005) 204-211
8. Sugawara J., Mitsui-Saito M., Hayashi C., et al. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 90 (2005) 5329-5332
9. Grisar J.C., Aletaha D., Steiner C.W., et al. Endothelial progenitor cells in active rheumatoid arthritis: effects of TNF and of glucocorticoid therapy. Ann Rheum Dis (2007)
10. Ablin J.N., Boguslavski V., Aloush V., et al. Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 79 (2006) 2364-2369
11. Palange P., Testa U., Huertas A., et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J 27 (2006) 529-541
12. Burnham E.L., Taylor W.R., Quyyumi A.A., Rojas M., Brigham K.L., and Moss M. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 172 (2005) 854-860
13. Yamada M., Kubo H., Ishizawa K., Kobayashi S., Shinkawa M., and Sasaki H. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax 60 (2005) 410-413
14. Martich G.D., Boujoukos A.J., and Suffredini A.F. Response of man to endotoxin. Immunobiology 187 (1993) 403-416
15. Marsik C., Mayr F., Cardona F., Derhaschnig U., Wagner O.F., and Jilma B. Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br J Haematol 121 (2003) 653-656
16. Pernerstorfer T., Hollenstein U., Hansen J.B., et al. Lepirudin blunts endotoxin-induced coagulation activation. Blood 95 (2000) 1729-1734
17. Stephens R.C., O'Malley C.M., Frumento R.J., Mythen M.G., and Bennett-Guerrero E. Low-dose endotoxin elicits variability in the inflammatory response in healthy volunteers. J Endotoxin Res 11 (2005) 207-212
18. Mayr F.B., and Jilma B. Coagulation interventions in experimental human endotoxemia. Transl Res 148 (2007) 263-271
19. Mittermayer F., Pleiner J., Schaller G., et al. Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humans. Eur J Clin Invest 33 (2003) 758-761
20. Hollenstein U., Homoncik M., Stohlawetz P.J., et al. Endotoxin down-modulates granulocyte colony-stimulating factor receptor (CD114) on human neutrophils. J Infect Dis 182 (2000) 343-346
21. Mayr F.B., Spiel A., Leitner J., et al. Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med 171 (2005) 354-360
22. Friedrich E.B., Walenta K., Scharlau J., Nickenig G., and Werner N. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98 (2006) e20-e25
23. Mittermayer F., Pleiner J., Schaller G., et al. Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol 289 (2005) H1752-H1757
24. Asahara T., Takahashi T., Masuda H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
25. Adams V., Lenk K., Linke A., et al. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 24 (2004) 684-690
26. Celletti F.L., Waugh J.M., Amabile P.G., Brendolan A., Hilfiker P.R., and Dake M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7 (2001) 425-429
27. Korbling M., Reuben J.M., Gao H., et al. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Transfusion 46 (2006) 1795-1802
28. Derhaschnig U., Reiter R., Knobl P., Baumgartner M., Keen P., and Jilma B. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 102 (2003) 2093-2098
29. Seeger F.H., Haendeler J., Walter D.H., et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111 (2005) 1184-1191